| abstract |
Therapies using TGFβ inhibitors, PD-1 inhibitors, and/or chemotherapeutic agents are disclosed. These drugs at certain doses (including flat dosing) and regimens can be used to treat or prevent proliferative diseases such as solid tumors, including pancreatic or colorectal cancers. Further combination and uses thereof are also disclosed. |